↓ Skip to main content

Comparative analysis of the safety and effectiveness of Nirmatrelvir-Ritonavir and Azvudine in older patients with COVID-19: a retrospective study from a tertiary hospital in China

Overview of attention for article published in Frontiers in Pharmacology, July 2024
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter
4 X users
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Comparative analysis of the safety and effectiveness of Nirmatrelvir-Ritonavir and Azvudine in older patients with COVID-19: a retrospective study from a tertiary hospital in China
Published in
Frontiers in Pharmacology, July 2024
DOI 10.3389/fphar.2024.1362345
Pubmed ID
Authors

Nan Shang, Xianlin Li, Zhiyu Guo, Lan Zhang, Shanshan Wang

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 August 2024.
All research outputs
#18,065,668
of 26,432,239 outputs
Outputs from Frontiers in Pharmacology
#8,033
of 20,472 outputs
Outputs of similar age
#89,566
of 182,111 outputs
Outputs of similar age from Frontiers in Pharmacology
#48
of 329 outputs
Altmetric has tracked 26,432,239 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 20,472 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.5. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 182,111 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 39th percentile – i.e., 39% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 329 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.